1 AtkinsRéalis: AtkinsRéalis was created in September 2023 and is an amalgamation of Atkins, Faithful+Gould and SNC-Lavalin. The new firm was unable to provide a breakdown of chartered staff numbers ...
Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback